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Summary 
We report the patterns of variability in transferrin structure in pregnancy, iron 
deficiency anemia, women using oral contraceptives, nonanaemic rheumatoid arth- 
ritis, iron deficient rheumatoid arthritis and anemia of the chronic diseases. Changes 
in microheterogeneity were assessed by crossed immuno isoelectric focusing of serum 
transferrin. Intra-individual variation in the control group was minimal. Equally, 
inter-individual variation in controls and groups with established stable disease was 
very limited. In pregnancy an increase in transferrin concentration was accompanied 
by redirection of glycan synthesis to the highly sialylated and highly branched 
glycans, an effect also shown in women using oral contraceptives. Iron deficiency 
anemia was accompanied by increased protein core synthesis without the large shifts 
in the microheterogeneity pattern as seen in pregnancy at similar transferrin concen- 
tration. In contrast to this, rheumatoid arthritis was accompanied by decreased pro- 
tein synthesis while the microheterogeneity pattern shifted significantly towards the 
highly branched glycans. Interpreted in the respective pathophysiological contexts 
results show that: (1) N-linked glycosylation of transferrin is a strictly controlled 
process, both in the physiological states and in disease. (2) Microheterogeneity is 
determined independently from transferrin protein synthetic rate. (3) Provisionally 
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observed changes in the glycosylation can modulate the biological activity of the 
glycoprotein and as a result redirect internal iron fluxes. This proposition can be ap- 
plied to altered iron metabolism in both pregnancy, oral contraceptives and 
rheumatoid arthritis. Changes are not operative in iron deficiency because 
qualitatively iron metabolism is not altered in this state. 
Introduction 
Transferrin (Tf) plays a key role in iron hqmeostasis in vertebrates, and possibly 
also in some invertebrates, as an iron transporting protein. In humans structural 
determinants of the protein have been extensively investigated (for reviews see Refs. 
l-3). Tf is a bilobed monomeric protein, the lobes corresponding to the chemically 
defined homologous N-terminal and C-terminal domains. The C-terminal domain 
carries the two N-linked complex type oligosaccharide chains, which in principle can 
be any one of a wide array of structures differing in degree of branching and terminal 
carbohydrate composition [3]. Tf is a convenient model for studying N-glycosylation 
because it is present in relatively high concentrations in many body fluids, its number 
of glycosylation sites is known and possible glycan structures have been structurally 
defined. Crossed immuno isoelectric focusing of iron saturated serum samples is a 
sensitive method of assessing this variability [4], providing an accurate account of 
the proportions of the fractions characterized by the number of sialic acids. Varia- 
tion in glycan structure due to changes in neutral carbohydrate residues is not direct- 
ly measured, but indirectly most of this variability is registered since a good 
estimation of the relative amounts of the Tfs that can be distinguished on the basis 
of the number of branches on the two glycans attached to the Tf molecule is 
provided by this technique. Remaining variation due to electro- 
phoretically neutral variation in glycan structure hidden from this technique is 
accepted, albeit anticipated to be minimal in serum samples in view of uniformity 
in glycan core structure and the existence of potent scavenging systems for 
asialoglycoproteins [3,4]. Carbohydrate analysis of isolated fractions confirming the 
basis for this separation has been published recently [5]. 
Even in cases related to an inborn error of metabolism directly involving N- 
glycosylation [6,7], attempts to electrophoretically identify unique subfractions in 
patients sera pathognomonic for the existence of a particular disease, have been un- 
successful [g-lo]. As opposed to this, our approach has been to describe and com- 
pare whole spectra of microheterogeneous forms of a glycoprotein with respect o 
both percentual representation and to actual concentrations of fractions in serum. 
This paper reports on the patterns of variability in Tf structure in several conditions 
(Table I) and in doing so aimed to identify factors that contribute to the regulation 
of Tf glycosylation. As explained in the discussion, through the respective denomina- 
tions of (patho-) physiological circumstances this wide range of groups was expected 
to shed light on regulatory aspects of Tf protein and glycan synthesis and along the 
same line we expected to obtain some clues on the role of Tf microheterogeneity in
iron metabolism, a field which has as yet received little attention. 
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TABLE I 
Investigated groups 
I+signation Group description n 
C 
N 
Control males 
Control females 
8 
13 
I Pregnant women, week 8-16 12 
II Pregnant women, week 17-26 10 
III Pregnant week 27-40 women, 18 
AT Pregnant women, a terme week 36-40 9 
PP 3 days post partum 9 
PPM 5 weeks postpartum 7 
0 
Fe 
RA-NA 
RA-Fe 
RA-ACD 
Women on oral contraceptives 7 
Iron deficiency anemia 9 
Rheumatoid arthritis, not anemic 6 
Rheumatoid arthritis, iron deficiency 6 
Rheumatoid arthritis, anemia of the chronic diseases 6 
Materials and Methods 
Patients 
After acquiring informed consent, blood was obtained from 21 healthy volunteers, 
8 male and 13 female (all women in first half of menstrual cycle), 56 pregnant women 
attending the University Hospital Obstetrical Clinic, 7 women using oral contracep- 
tives, 9 women with iron deficiency anemia and 18 female patients with rheumatoid 
arthritis (RA) fitting the revised ARA-criteria [ 111. Anemic pregnant women and 
pregnant women with a latent iron deficiency were excluded by hemoglobin and 
serum ferritin measurements. The course of pregnancy and delivery was un- 
complicated in all cases. All 18 female RA patients had active disease and used non- 
steroidal anti-inflammatory drugs, as well as long-acting anti-rheumatic drugs. 
Other causes of anemia were excluded by history taking (present or past ulcer disease 
or other complaints or signs of gastrointestinal diseases, hypermenorrhoea nd 
haematuria), negative stools for occult blood, a normal vitamin B12, folic acid, 
Coombs test, creatinine clearance and absence of microscopic hematuria. The female 
RA patients were divided into three groups of six: nonanemic patients, patients with 
iron deficiency anemia and patients with anemia of the chronic diseases. This distinc- 
tion has been made on established criteria based on hemoglobin, serum Tf and serum 
ferritin measurements [ 12,131. 
Sample treatment 
Venous blood samples were obtained between 1O:OO ,and 12:00 h in glass tubes not 
containing anticoagulant. Omitting the anticoagulant is a relevant part of the pro- 
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cedure as we and others have found that the addition may influence the isoelectric 
focusing [14]. After clot retraction, the sample was centrifuged for 20 min at 
1,200 x g and 4°C. The serum was used immediately or stored at -20°C or -70°C 
until use. Before storage or application on the gels complete iron saturation of the 
Tf was ensured by mixing 100 ~1 serum with 5 ~1 of 0.5 M NaHCOs and 3 ~1 of 10 
PM Fe(II1) citrate which was then left at room temperature for 1 h. Rabbit anti 
human Tf-anti sera were home made and have been compared favourably with anti 
sera from Dako, Denmark. 
Crossed immuno-isoelectric focusing (CIEF) 
This method involves two phases combining two electrophoretic techniques; the 
first establishing separation of proteins of interest, the second run perpendicularly 
to the first for identification and quantification purposes. 
In the first phase the Tf subfractions were separated on polyacrylamide gelstrips 
on an immobilized pH-gradient by isoelectric focusing. Strips, 4 mm wide, cut from 
an Immobiline Dry Plate, pH 4.9-6.1 (purchased from LKB-Produkter AB, Brom- 
ma, Sweden), which had previously been rehydrated in aqua bidest to a final weight 
of 20 g/gel, were placed on a thermostatic template kept at 10°C. Anode and cathode 
strips soaked in 10 mM glutamic acid and 10 mM NaOH, respectively, were placed 
over the ends of the immobiline strips. Two milliliters of the iron-saturated serum 
was applied at the cathodal side of the strips. A voltage of 1 kV was applied during 
18 h at 10°C. 
For the second phase of the electrophoretic procedure, 60 ml of a 1% (w/v) solu- 
tion of Agarose-M (LKB) in 24-mM sodium barbiturate-HCl buffer, pH 8.7, 
prepared at 100°C were cooled to 55°C whereupon a preheated (55°C) amount of 
the rabbit anti-human Tf preparation was added and thoroughly mixed with the 
agarose solution. This mixture was poured onto a preheated glass plate (130 x 260 
mm) placed on top of a second glass plate kept at 50°C. Then the Immobiline strips 
from the isoelectric focusing step, having been soaked for 15 min in the electrophore- 
sis buffer, were placed upside down on the agarose surface. The crossed immunoelec- 
trophoresis is carried out in the 24-mM barbiturate-HCl buffer during 4 h at 10°C 
at a voltage of 12- 13 V/cm. All determinations were done in duplicate. The fractions 
were successively quantitated via measurement of the areas enclosed by the im- 
munoelectrophoretic peaks. In Fig. 1 a representative xample is shown of a 
microheterogeneity pattern. 
Tf concentrations were measured turbidimetrically [ 151 using the Boehringer 
ES22. For this Tf was immunoprecipitated with sheep-anti-human-Tf (purchased 
from Boehringer) in an 0.1 M Na2HP04/KH2P04 buffer, pH 7.5, containing 4% 
polyethylene glycol. Ferritin concentrations were measured by ELISA. 
Known Tf functions are concentration dependent processes. Therefore concentra- 
tions rather than ratios of subfractions are probably more important in the 
biological functions of Tf. Thus in all groups individual concentrations have been 
equated from fractional ratios and total Tf concentration. In pregnancy and other 
groups this adjusts the effects to its physiological proportions, as fraction ratios 
(assuming unaltered, similar’serum half lives) justly describe the adaptation of syn- 
I I I I I I I I I I I 
5.1 5.5 5.9 
Fig. 1. CIEF serum sample. Numerals indicate number of sialic acid residues per protein molecule. 
Cathode at right and bottom for first and second phase, respectively. 
thesis, but in conditions where total protein synthesis increases as well, this presenta- 
tion may overstate the possible physiological implications. 
Statistical analysis 
Total Tf concentrations were compared using the two tailed Student’s t-test and 
non-parametric data by the Mann-Whitney U-test. Coefficients of correlation were 
compared using Spearman’s test. 
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Results 
In Tables II-IV a full account of the results is given. Groups of patients have been 
designated as explained in Table I. Between males and control females no significant 
differences existed in diferric Tf spectrum, total and fractional Tf concentrations. 
Of a number of control male individuals repeated blood samples have been taken. 
These data show that there was very little variation in the spectrum of sialo-Tf 
variants in the course of 3 months (Table II). 
Besides confirming the recognized effect of pregnancy on total Tf synthesis, our 
results showed a consistent, progressive redirection of synthesis towards highly 
sialyiated transferrins in the course of pregnancy. This effect became statistically 
significant in the second trimester and the trend appeared to be continued up to the 
last week of pregnancy. Compared to any of the other investigated groups pregnancy 
had the most pronounced effect on the mi~roheterogeneity pattern. After delivery, 
changes were rapidly reversed. This was demonstrable as early as 4 days after 
delivery and 5 weeks later both concentrations and subfraction-pattem had virtually 
normalised (Tables III, IV and Fig. 2). The trisialo-Tf decreased si~i~cantly in its 
percentual representation and the disialo-Tf was maintained at a constant level. 
Women using oral contraceptives displayed a similar trend: concentration of total 
Tf was increased and compared with the propo~ional dist~bution in controls, more 
of the increase was accounted for by the highly sialylated variants. Compared to 
pregnancy it differed in that at the same level of inurement of total Tf concentration 
the change in the proportional representation was less marked than in pregnancy. 
Iron deficiency was accompanied by an increased total Tf concentration, the group 
average being risen by 48.2%. Relative proportions were shifted considerably less 
towards the highly sialylated fractions, reaching statistical significance only for the 
TABLE II 
Variation of pattern in control male ~ndi~duals 
Proportional distribution of sialo-Tfs (%) 
mono di tri tetra penta bexa hepta 
Average 
(n = 4) 
Maximum 
inter-individual 
variation 
(n=_W) 
Maximum 
intra-individual 
variation 
(n = 12) 
0.0 2.6 1.4 66.1 18.9 4.9 0.1 
0.0 1.1 2.1 2.6 1.5 1.9 0.i 
0.0 0.2 0.5 0.8 0.6 0.3 0.1 
Proportional distribution of sialo-Tf fractions in four male controls in the course of 3 months. Results 
expressed as percentages of total amount. Total variation of the spectrum within a single indi~dual 
ranged from 1.1 to 2.3%. 
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pentasialo-Tf. Compared to pregnancy total Tf concentration in iron deficiency was 
higher and most of the actual increment in concentration was due to increased pro- 
duction of tetrasialo-Tf. 
The patients with active RA generally had a lowered total Tf concentration. The 
decrease was less in the subgroup with concomitant iron deficiency, but still 
significantly low compared to healthy controls. The microheterogeneity pattern was 
again changed in favour of the highly sialylated Tfs. This change was least pronounc- 
ed in the nonanemic RA patients and most pronounced in the anemia of the chronic 
disorder (ACD) group, with the iron deficiency group occupying the intermediate 
position. The synthetic balance was shifted to the extent that in both the iron deti- 
ciency and ACD-subgroups the concentrations of penta, hexa and heptasialoTfs 
were not significantly depressed compared to controls, while the total Tf concentra- 
tion in these groups was diminished by 15.1% and 38.8%, respectively. The 
tetrasialo-Tf was significantly depressed in both proportional representation and in 
concentration in all RA subgroups; and a similar effect is observed for the di- and 
trisialo-Tf. 
Discussion 
A global shift of synthesis towards highly sialylated and more branched chains in 
all conditions understates the information available from these results. Reviewing 
results in the context of contemporary understanding of both the underlying 
pathophysiological conditions and the mechanism from which microheterogeneity 
evolves disclosed additional conclusions. 
Identification of factors influencing microheterogeneity patterns 
Results from pregnant women (Tables III, IV and Fig. 2) clearly show adaptation 
of Tf glycan synthesis in the course of pregnancy. The tetrasialo-Tf concentration 
increases despite its proportional decrease, the major part of the increase in the total 
Tf concentration during pregnancy, however, is due to the increase in the concentra- 
tion of highly sialylated Tfs. No significant change in the concentration of the 
desialylated Tfs is registered, which is consistent with an adequately functioning 
asialoglycoprotein scavenger system. 
Endocrinological influences on the microheterogeneity pattern, were further 
ascertained comparing women on oral contraceptives and women suffering from an 
isolated iron-deficiency anemia with controls and pregnant women (Fig. 3). In 
women on oral contraceptives the pattern changes in the same direction as in preg- 
nancy, as such confirming the notion that oral contraceptives can influence the 
glycosylation system with reference to Tf [ 161. Compared to pregnancy, at the same 
level of increment of total Tf concentration, the change in proportional representa- 
tion was less marked in women using oral contraceptives. This difference in pattern 
may be related to the difference in the estrogen to progesterone ratio as the latter 
is higher in pregnant women than in the OAC group. Progesterone has been reported 
to influence glycosylation, data on estrogen are limited to stimulation of total Tf syn- 
thesis. Therefore the above described difference could be explained on the basis of 
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these assumptions. Alternative explanations lie in the preponderance of other hor- 
mones in pregnancy. Prolactin can probably be excluded in view of the rapid nor- 
malization of the microheterogeneity pattern after delivery in lactating women, but 
as such endocrinological influences are certainly significant. 
As reflected in clinical chemical parameters, the rheumatoid arthritis groups com- 
prise a spectrum of disease activity [ 13,171; in order of increasing disease activity the 
nonanaemic, the iron deficient and the ACD group. Changes in microheterogeneity 
are again similar in direction, but this time protein synthesis is significantly reduced 
as a concomitant feature of the acute phase reaction. As the alteration in glycosyla- 
tion was more pronounced in the anemic groups with the ACD group displaying the 
greatest change in pattern, change in glycosylation of Tf in RA appears to be cor- 
related with disease activity (Fig. 4) confirming conclusions drawn from studies on 
concanavalin A binding patterns of o1 acid glycoprotein [ 181. The decreased con- 
centration of the disialo- and trisialo-Tf in RA is significant and this also appears 
to correlate with disease activity. The latter can be interpreted as resulting from the 
activation of the asialoglycoprotein scavenging system in the acute phase reaction, 
thus working at higher efficiency. The higher avidity of this system as such for 
desialylated tri- and tetra-antennary glycans [19] may be an additional factor. 
Regulatory aspects of N-glycosylation and protein synthesis 
Reviewing glycan synthesis being beyond the scope of this article [20-231 it will 
sufftce here to briefly indicate the context for reference. Evolutionarily glycan syn- 
thesis is one step up the ladder compared to protein synthesis, particularly in its 
coding mechanism. Through both the possibility of branching and a combination of 
anomerous configurations and types of bonding between identical sets of com- 
ponents, a vast combination of structural determinants is created, as in other 
macromolecular synthetic machineries, but glycans are distinct from polypeptides 
and nucleic acids in the comparatively small size at which analogous astronomic di- 
versity is attained. It is also distinct from nucleic acid and polypeptide synthesis in 
that it is not coded for by an accurate template mechanism. In essence glycan struc- 
ture is coded for by intrinsic information laid down in the combination of primary, 
secondary and tertiary characteristics of the polypeptide core structure, in conjunc- 
tion with characteristics of enzymes involved in the synthetic machinery as well as 
the interaction with the matrix in which it is processed. Consequently outcome is not 
explicitly defined, at the cost of loss of uniformity, hence the phenomenon of 
microheterogeneity. 
From this understanding it evolved that amongst others the results of the CIEF 
of serum Tf can be appreciated as a means of assessment of the accuracy of control 
over the glycosylation system. Our results are based on a technique that provides a 
very accurate and reproducible measure of Tf microheterogeneity. In view of the 
complexity of the synthetic system and its control, it is clear how little variation there 
in fact is in the oligosaccharide-structures attached to this particular protein. 
Although some heterogeneity is still hidden from isoelectric focusing, only 9 dif- 
ferent fractions can be distinguished in iron saturated human serum. As shown in 
Table II, in single individuals the variation in this microheterogeneity is minimal. 
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Also in all groups with established disease/physiological states the pattern of 
distribution was similarly remarkable in its uniformity. Variation in micro- 
heterogeneity can therefore not just be the result of random variation. The consis- 
tency of isoelectric focusing patterns characterizes the system in a broad sense, 
demonstrating that the process must be governed by a very potent control system, 
although the mechanism, apart from identification of constituting elements, is still 
beyond our perception. 
A second conclusion within the same context refers to the coupling between pro- 
tein and glycan synthesis. Results on sera from pregnant women already indicate 
that protein core synthesis and change of glycosylation towards higher branched 
glycans are not linked, since the increment in the forms with tri- and tetra-antennary 
chains correlated better with duration of gestation than with concentration of total 
Tf (Fig. 5). Women on oral contraceptives attain a lower level of change in 
microheterogeneity when compared to that stage in pregnancy where total Tf con- 
centrations are similar, which indicates that changes in microheterogeneity and Tf 
protein synthesis are not linked. The most persuasive argument is provided in the 
results from the RA-group. In acute and chronic inflammatory conditions increased 
synthesis of acute phase proteins is invariably accompanied by changes in the 
microheterogeneity spectrum, at the least not incompatible with a linkage. Tf being 
a negative acute phase protein [24], it provides the model in which the effect of pro- 
tein synthetic rate on N-glycosylation is dissociated from the effect of the acute 
phase response on glycosylation. The microheterogeneity pattern can be changed 
markedly even when protein synthesis is significantly depressed. Therefore a fixed 
linkage between Tf protein synthetic rate and glycosylation pattern can be denied. 
Hypothesis on the role and rationale of glycosylation changes viz-a-viz physiological 
and pathophysiological requirements for iron 
Having concluded that observed changes in Tf microheterogeneity are not just 
related to random faults or a byproduct of increased synthetic rate, but the result 
of strictly controlled redirection of glycan synthesis, the next question that arises is 
whether these changes in Tf have any functional significance, or is Tf simply an inno- 
cent bystander as it happens to pass the synthetic machinery that has been adjusted 
for other reasons. To address this question results are reviewed in their 
pathophysiological contexts. 
Pregnancy 
The adaptation of the microheterogeneity pattern in the course of pregnancy in 
timing closely coincides with the major changes in iron metabolism as they occur 
during pregnancy. The increased demand of the fetoplacental unit and maternal 
bone marrow for iron is partly counterbalanced by cessation of menstruation. The 
remainder is partly met by increased iron absorption from the gut. The cumulated 
demand for iron may increase to above 8 mgday, which exceeds the uptake rate 
from the gut, therefore mobilization of iron from storage sites is an important 
mechanism in pregnancy, particularly in the later stages. The correlation between the 
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microheterogeneity-shift 
versus duration of pregnancy 
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Fig. 5. Correlation diagrams displaying redirection of Tf gtycan synthesis related to duration of pregnancy 
(top) and to total Tf concentration (bottom). Difference in correlation to duration significantly higher 
than correlation to Tf concentration; P < 0.001. 
increment in the production of highly siafyiated Tfs and combined daily maternal 
and fetoplacental iron needs, combined with the absence of correlation with the pro- 
duction of tetrasialoTf, is striking (Fig. 6). As both major iron requiring processes, 
i.e. maternal erythroblast iron uptake and iron uptake on the maternal side of the 
placenta have been shown to be dependent on the interaction between Tf and the 
Tf receptor, the obvious conclusion is to relate these changes in ~croheterogeneity 
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Microheterogeneity in pregnancy 
in relation to iron requirement 
iron required mg/day production ratio 
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9 
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Fig. 6. Iron requirements during pregnancy and Tf microheterogeneity. (A) Iron requirement in mgiday. 
(B) pentasialo-Tf production ratio. (C) Tetrasialo-Tf production ratio. Iron requirement increasing 
almost exponentially until term mostly as a result of the steadily increasing transplacental iron transport 
and the increase of maternal red cell mass occurring predominantly in the third trimester. Shifts in 
microheterogeneity plotted as ratio between production before and at time of gestation and corrected for 
increased vascular fluid mass. 
to increased iron fluxes. This concept of redirection of iron fluxes through modula- 
tion of functional characteristics of the molecule without affecting the protein moie- 
ty and independent from its rate of production is one that has a certain attraction, 
but admitted, coincidental concurrence can certainly not be excluded and the con- 
cept must await experimental verification. However, some additional weight is added 
to the argument by observations in other diseases (see paragraphs on iron deficiency 
anemia and RA). Also in our department we have completed studies on apical 
microvillous surface membrane vesicles isolated by a modified Smith-procedure [25], 
the modification involving a choatropous treatment. These vesicles were incubated 
with tetra- and hexasialo-Tf isolated by preparative isoelectric focusing of genetically 
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homogeneous Tf [5]. Scatchard analyses how that at least at low concentrations the 
hexasialo-Tf has a higher affinity for membrane vesicles prepared from term placen- 
ta villi than the tetrasialo-Tf (preliminary data, not shown). 
Iron deficiency anemia 
Iron deficiency is a condition that can be simply defined as a state of global 
physical demand for iron in the organism. Having postulated a functional role for 
the change in glycosylation in iron metabolism via modification of functional 
characteristics of Tf a dilemma is thus created: what rationale is there to account for 
the fact that changes in obviously the pre-eminently iron demanding condition are 
less prominent than in pregnancy ? 
The answer may lie in both the nature and the site of generation of the signal to 
adapt to the stress the organism is subjected to in each particular condition. In iron- 
deficiency the matter is above all to absorb more iron from the gut and not so much 
to redistribute as to distribute any of the available iron as all tissues are devoid of 
iron. Tf plays no active role in absorption of iron from the intestines [3], denying 
a role for changes in Tf substructure in it as well. Secondly, the single most impor- 
tant site of production of Tf that ends up in the circulation is the liver, which itself 
through the Iron Responsive Elements incorporated in the genetic control of Tf pro- 
tein synthesis turns the signal for synthesis on and off. On the contrary in pregnancy 
in essence the fetus, through regulation of the hormonal milieu in concert with the 
placenta, controls the whole range of maternal metabolic, hematologic and even car- 
diovascular adaptations to pregnancy [26]. Also, in the absence of anemia increased 
erythropoiesis is forced upon her, dictated by the fetoplacental unit. Even more so 
than in iron deficiency iron must be lured away from storage sites or preferentially 
be taken up by other organs than those involved in storage, explaining the logic for 
a physiological mechanism different to that in iron deficiency anemia. 
Rheumatoid arthritis (RA) 
Referring to the relative conservation of the production of highly sialylated Tfs, 
the above postulated facilitation of iron fluxes to the bone marrow through Tf 
glycan modulation can also be incorporated in the interpretation with respect o RA. 
In view of the high correlation of disease activity and shift in microheterogeneity pat- 
tern, the conservation of highly branched glycans may form part of a compensatory 
mechanism in anemias accompanying RA, attempting to facilitate a decreased 
erythroblast iron availability which has been postulated to be a major contributing 
factor in this condition. This decreased iron availability may rely on inhibitory 
effects of cytokines such as the interleukins and TNF, factors that have been shown 
to correlate highly with disease activity (26,271. The same mechanism would of 
course also be operable in the disease stages not accompanied by ACD, but then be 
compensated for. In ACD this compensation appears to finally fall short. Of course 
this notion is based on correlations only and one could just as reasonably turn the 
argument around. For instance it can be postulated that anemia of the chronic 
diseases arises when the tetra-sialo-Tf concentration falls below a critical level. 
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Conclusion 
Clearly experimental data are needed. A convenient method for isolation of 
microheterogeneous forms of Tf has been developed [5] enabling us to study effects 
of different fractions on various cell types, but unfortunately a synthetic model is 
lacking at present. A cell culture model will have to be based on hepatocytes as the 
liver is the main source of Tf in the circulation. Unfortunately, the hepatocellular 
carcinoma cell lines PLC/PRF/S, HepG2 and Hep3B produce Tfs with unusual 
acidic isoelectric points (own observations, results not shown) and for that reason 
unsuitable for studying effects of hormonal changes in pregnancy, effects of 
mediators of the acute phase response or the effects of iron deficiency. For the 
moment we have relied on observations in physiological and pathological states and 
analyzed data with careful reference to the conditions they intrinsically define. 
In conclusion, our results show that the glycosylation of Tf is a strictly controlled 
process, both in the physiological states and in disease. The microheterogeneity pat- 
tern is determined independently from Tf protein synthetic rate. Estrogens and 
possibly more so progestagens can influence microheterogeneity. Mediators of the 
acute phase response can clearly be involved as well, experimental verification is 
however difficult due to the absence of an in vitro model. 
In pregnancy an increase in Tf concentration is accompanied by redirection of 
glycan synthesis to the highly sialylated and highly branched glycans. The close cor- 
relation of this phenomenon throughout pregnancy with iron requirements as defin- 
ed largely by transplacental iron transport and bone marrow iron consumption led 
us to postulate that this redefinition of the microheterogeneity pattern may function 
as a means to modulate internal iron fluxes between sites of storage and utilization. 
Similarly this proposition can be applied to RA, where a similar shift in the pattern 
is observed, in which case the mechanism may serve as a means of compensation for 
the decreased erythroblast iron availability which characterizes this condition. 
Experimental work probing these conclusions is in progress. 
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